References
- Spector TD. Rheumatoid arthritis. Rheum Dis Clin North Am 1990; 16: 513–537
- Thomas DJ, Young A, Gorsuch AN, Bottazzo GF, Cudworth AG. Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease. Ann Rheum Dis 1983; 42: 297–300
- Fischman AS, Abeles M, Zanetti M, Weinstein A, Rothfield NF. The coexistence of rheumatoid arthritis and systemic lupus erythematosus: A case report and review of the literature. J Rheumatol 1981; 8: 405–415
- Andonopoulos AP, Drosos AA, Skopouli FN, Acritid AC, Moutsopoulos HM. Secondary Sjogren's syndrome in rheumatoid arthritis. J Rheumatol 1987; 14: 1098–1103
- Scofield RH. Autoantibodies as predictors of disease. Lancet 2004; 363: 1154–1156
- Cataldo F, Marino V. Increased prevalence of autoimmune diseases in first-degree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 2003; 36: 470–473
- Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin Gastroenterol 2006; 22: 674–679
- van de Sluijs Veer G, Vermes I. IgG autoantibodies against tissue transglutaminase in relation to antinuclear antibodies. Clin Chem 2001; 47: 952–954
- Villalta D, Bizzaro N, Tonutti E, Tozzoli R. IgG anti-transglutaminase autoantibodies in systemic lupus erythematosus and Sjogren Sindrome. Clin Chem 2002; 48: 1133
- Spadaro A, Sorgi ML, Scrivo R, Picarelli A, Tola MD, Sabbatella L, Taccari E. Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies. Reumatismo 2002; 54: 344–350
- Birò E, Szekanecz Z, Czirjak L, Dankò K, Kiss E, Szabò NA, Szucs G, Zeher M, Bodolay E, Szegedi G, Bakò G. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 2006; 25: 240–245
- Carbon P, Lassoued S, Dromer C, Oksman F, Fournei A. Prevalence of thyroid abnormalities in patients with rheumatoid arthritis. Thyroidology 1992; 4: 99–102
- Szegedi G, Bakò G. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 2006; 25: 240–245
- Norden AG, Jackson RA, Norden LE, Griffin AJ, Barnes MA, Little JA. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin Chem 1997; 43: 957–962
- Burmester GR, Mariette X, Montecucco C, Monteagudo-Sãjez I, Malaise M, Tzioufas AG. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: The Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis 2007; 66: 739
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324
- Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P. Autoimmunity and anti-TNF-agents. Ann NY Acad Sci 2005; 1051: 559–569
- Atzeni F, Sarzi-Puttini P, Dell'Acqua D, De Portu S, Cecchini G, Cruini C, Carrabba M, Meroni PL. Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: A one year prospective study. Arthritis Res Ther 2006; 8(1)R3
- Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4. Ann Endocrinol (Paris) 2001; 62: 193–201
- Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004; 63: 1437–1441
- Toh BH, Van Driel IR, Glesson RA. Pernicious anemia. N Engl J Med 1997; 337: 1441–1448
- Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999; 30: 394–401
- PietroPaolo M, Eisenbarth GS. Autoantibodies in human diabetes. Curr Dir Autoimmun 2001; 4: 252–282